CCI4EU - What does a Comprehensive Cancer Infrastructure do?
MATERIALS AVAILABLE
CCI4EU - What does a Comprehensive Cancer Infrastructure do?
MATERIALS AVAILABLE
Chairs: Simon Oberst, DK - Eva Jolly, SE
Introduction
CCI4EU (Comprehensive Cancer Infrastructures for the European Union) is a European project aiming to help Member States and Associated Countries improve or develop their existing or future Comprehensive Cancer Infrastructures (CCIs), by helping develop their research & innovation-related capacities.
This course is the first of 10 online training courses organised within the project to help countries develop an effective comprehensive infrastructure and widen the reach of this grant. The topic of this first online course is: What does a Comprehensive Cancer Infrastructure do?
This course is the first of 10 online training courses organised within the project to help countries develop an effective comprehensive infrastructure and widen the reach of this grant. The topic of this first online course is: What does a Comprehensive Cancer Infrastructure do?
The aim is to look into the components of a comprehensive cancer infrastructure, exploring how it operates to enhance patient care, foster groundbreaking research, and empower communities.
Target audience
People involved in management, coordinators, clinicians, researchers, and directors.
Course delivery
This online course was held live on July 4th via this webpage. The entire course was recorded and is now available as on-demand material.
To access the on-demand materials (after the live streaming), participants must register to the course, login to the e-ESO platform and click on the play buttons inside the course programme.
To access the on-demand materials (after the live streaming), participants must register to the course, login to the e-ESO platform and click on the play buttons inside the course programme.
Official language
The course was held in English. Translations are not provided, but English subtitles can be activated and transcriptions can be automatically translated using free online tools.
Registration
Registration to the course is free but mandatory.
Certificate of attendance
Participants (both live and on-demand) will be issued a certificate of attendance once they have completed a minimum attendance of 75% of the entire course. An online evaluation questionnaire must be completed in order to receive the certificate that will be issued by email. The evaluation questionnaire will appear in the right-hand column of the course page when participants have completed the course.
Organising secretariat
Sarah Goldman: sgoldman@eso.net
Francesca Marangoni: fmarangoni@eso.net
Sonia Bulgarelli: sbulgarelli@eso.net
Francesca Marangoni: fmarangoni@eso.net
Sonia Bulgarelli: sbulgarelli@eso.net
04/07/2024 14:00
LIVE STREAMING
04/07/2024 14:01
Introduction
14:00
Introduction and welcome
Eva Jolly (SE) Simon Oberst (BE)14:05
What is a CCI?
Simon Oberst (BE)14:20
Why do we need a CCI?
Eva Jolly (SE)04/07/2024 14:35
CCI Concept
14:35
Structure of a CCI and difference between CCI and CCC
Mef Nilbert (SE)14:55
Q&A
04/07/2024 15:05
How research findings can improve care...
15:05
...through translational research
Elias Arnér (SE)15:25
...through clinical research
Javier Carmona (ES)15:45
Q&A
04/07/2024 15:55
Education, training and multidisciplinarity
15:55
Using education and training to promote integration
Judith Neter (NL)16:15
Multidisciplinarity to assure quality in the patient pathway
Isabel T. Rubio (ES)16:35
Q&A
04/07/2024 16:45
How to form a CCI
16:45
Case study 1 - OncoZon (The Netherlands)
Fabrizia Ketelaars (NL)17:05
Case study 2 - FICAN (Finland)
Tomi Mäkelä (FI)17:25
Case study 3 - ICO (Spain)
Joan Brunet (ES)04/07/2024 17:45
Closing remarks
Elias Arnér
Karolinska Institutet, Biochemitry Department, Stockholm, SE
Eva Jolly
Karolinska Comprehensive Cancer Center, Board of Directors, Stockholm, SE
Fabrizia Ketelaars
Maastricht UMC, OncoZON, Maastricht, NL
Isabel T. Rubio
Clínica Universidad de Navarra, Breast Surgical Oncology Dpt., Madrid, ES
Javier Carmona
Vall d’Hebron Institute of Oncology (VHIO), Scientific Management Area, Barcelona, ES
Joan Brunet
Catalan Institute of Oncology, Dept. of Medical Oncology, Girona, ES
Judith Neter
Netherland Cancer Institute, ., Amsterdam, NL
Mef Nilbert
Lund University, Dept. Oncology, Institute for Clinical Sciences, Lund, SE
Simon Oberst
Organisation of European Cancer Institutes, Quality and Accreditation, Brussels, BE
Tomi Mäkelä
Finnish National Cancer Center FICAN, Board of Trustees, Helsinki, FI
This course is part of:
Funded by:
Funded by:
